Genomic Interrogation of Secondary-Type Acute Myeloid Leukemia: Response and Outcomes to Contemporary Therapies,” published in the February 2025 issue of American Journal of Hematology by Senapati et ...

Patients receiving an immune checkpoint inhibitor for a neoplasm face an increased risk for rheumatoid arthritis, an ...

More than one-quarter of blood or marrow transplant survivors developed cutaneous malignant neoplasms, according to study results.Researchers identified several risk factors, including older age, ...

A small phase 1 trial suggests that 'personalized' vaccines might battle advanced kidney cancers Patients had sustained and ...

MONDAY, Feb. 3, 2025 (HealthDay News) -- A person’s lifetime risk of cancer might be partly established before they are even ...

Each type of myeloproliferative neoplasm' manifests in different signs and symptoms depending on the type of blood cells affected. But they most commonly manifest in headaches, fatigue, and dizziness ...